Temozolomide plus thalidomide in patient
β
Wen-Jen Hwu; Eric Lis; Jennifer H. Menell; Katherine S. Panageas; Lynne A. Lamb;
π
Article
π
2005
π
John Wiley and Sons
π
English
β 98 KB
## Abstract ## BACKGROUND Temozolomide plus thalidomide is a promising oral combination regimen for the treatment of metastatic melanoma. The current Phase II study examined the efficacy and safety of this combination in chemotherapyβnaive patients with brain metastases. ## METHODS Patients with